InsidersTradesSigma
Explore the detailed record of transactions filed by Kruger Kurt H, Director. Insider active across 1 companies, notably Qualigen Therapeutics, Inc.. Cumulatively, 2 filings have been published. Total volume traded: €8k. The latest transaction was filed on 19 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Kurt H. Kruger is a Director at Qualigen Therapeutics, Inc. As a board member, he participates in the governance and strategic direction of the company, which focuses on developing innovative treatments in biotechnology.